Breast Cancer Clinical Trial

A Research Study for Latina Women With Breast Cancer

Summary

The purpose of this study is to examine the feasibility and preliminary efficacy of a psychosocial eHealth intervention designed to improve hormone therapy adherence among Hispanic/Latinx women with breast cancer. Our proposed secondary outcomes are health-related quality of life and self-efficacy in managing hormone therapy side effects.

The intervention components include breast cancer knowledge, hormone/endocrine therapy knowledge, stress awareness and management, social support, and enhanced communication and intimacy skills. The intervention will be delivered via a Smartphone application over a 12-week period.

All participants will receive the intervention application (described below). Aside from using the Smartphone application for the recommended 12 weeks, participation in this study includes three assessments: baseline (at the beginning of the research study), 6-week follow-up, and 12-week follow-up.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Female
Diagnosis of breast cancer, non-metastatic, stage 0-III (A, B, or C)
Receiving or received endocrine/hormone therapy within the last 3 years (36 months)
At least 18 years of age
Able to speak and read English or Spanish
Able to provide informed consent
Self-identify Hispanic/Latina ethnicity

Exclusion Criteria:

Stage IV or metastatic
Visual, hearing, voice, or motor impairment that would prevent completion of study procedures
Diagnosis of an unmanaged psychotic disorder, bipolar disorder, dissociative disorder, or other diagnoses for which participation in this trial is either inappropriate or dangerous - this includes patients who have a life-threatening illness (e.g., end-stage kidney disease) or diagnosis of a chronic disease that is associated with a major functional impairment (e.g., fibromyalgia)
Illicit substance or alcohol dependence
Suicidal ideation, plan, intent
Alzheimer's, dementia, or history of stroke
Scheduled reconstruction surgery within 1 month of any study procedures or involvement.

Study is for people with:

Breast Cancer

Estimated Enrollment:

60

Study ID:

NCT04861896

Recruitment Status:

Recruiting

Sponsor:

Northwestern University

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Northwestern University
Chicago Illinois, 60611, United States More Info
Diana Buitrago
Contact
312-503-2866
[email protected]

How clear is this clinincal trial information?

Study is for people with:

Breast Cancer

Estimated Enrollment:

60

Study ID:

NCT04861896

Recruitment Status:

Recruiting

Sponsor:


Northwestern University

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider